Katarzyna Malarz, Tainah Dorina Marforio, Robert Gawecki, Dominik Dreszer, Matteo Calvaresi, Maciej Serda
{"title":"The Water-Soluble [60]Fullerene Derivatives as Binders of SARS-CoV-2 Proteins","authors":"Katarzyna Malarz, Tainah Dorina Marforio, Robert Gawecki, Dominik Dreszer, Matteo Calvaresi, Maciej Serda","doi":"10.1021/acsmedchemlett.6c00282","DOIUrl":null,"url":null,"abstract":"<p>Water-soluble fullerene derivatives represent emerging\r\nmolecular\r\nnanomaterials for antiviral drug discovery, yet their target selectivity\r\nagainst SARS-CoV-2 proteins remains insufficiently defined. Here,\r\nfour functionalized [60]fullerenes, C<sub>60</sub>(OH)<sub>24</sub>, C<sub>60</sub>ser, C<sub>60</sub>ALA, and C<sub>60</sub>Trp, were\r\nevaluated as binders of key SARS-CoV-2 targets involved in viral entry\r\nand replication: spike glycoprotein, papain-like protease, 3CL main\r\nprotease, and RNA-dependent RNA polymerase. Microscale thermophoresis\r\nrevealed distinct target-dependent binding profiles governed by fullerene\r\nfunctionalization. The C<sub>60</sub>Trp fullerene was the most active\r\nderivative, binding Spike with nanomolar affinity (K<sub>d</sub> =\r\n94.8 nM) and showing micromolar affinity toward papain-like protease\r\nand 3CL main protease. Docking and molecular dynamics simulations\r\nsupported the preferential interaction of C<sub>60</sub>Trp with the\r\nspike protein cavity through combined fullerene cage complementarity\r\nand polar interactions with lysine and arginine residues. The tested\r\nderivatives showed low cytotoxicity in A549 cells, and C<sub>60</sub>Trp was efficiently internalized. These findings identify tryptophan-functionalized\r\n[60]fullerene as a promising multivalent scaffold for SARS-CoV-2 protein\r\ntargeting.</p>","PeriodicalId":20,"journal":{"name":"ACS Medicinal Chemistry Letters","volume":"17 10","pages":"2153–2159"},"PeriodicalIF":3.9000,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Medicinal Chemistry Letters","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsmedchemlett.6c00282","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/3 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Water-soluble fullerene derivatives represent emerging
molecular
nanomaterials for antiviral drug discovery, yet their target selectivity
against SARS-CoV-2 proteins remains insufficiently defined. Here,
four functionalized [60]fullerenes, C60(OH)24, C60ser, C60ALA, and C60Trp, were
evaluated as binders of key SARS-CoV-2 targets involved in viral entry
and replication: spike glycoprotein, papain-like protease, 3CL main
protease, and RNA-dependent RNA polymerase. Microscale thermophoresis
revealed distinct target-dependent binding profiles governed by fullerene
functionalization. The C60Trp fullerene was the most active
derivative, binding Spike with nanomolar affinity (Kd =
94.8 nM) and showing micromolar affinity toward papain-like protease
and 3CL main protease. Docking and molecular dynamics simulations
supported the preferential interaction of C60Trp with the
spike protein cavity through combined fullerene cage complementarity
and polar interactions with lysine and arginine residues. The tested
derivatives showed low cytotoxicity in A549 cells, and C60Trp was efficiently internalized. These findings identify tryptophan-functionalized
[60]fullerene as a promising multivalent scaffold for SARS-CoV-2 protein
targeting.
期刊介绍:
ACS Medicinal Chemistry Letters is interested in receiving manuscripts that discuss various aspects of medicinal chemistry. The journal will publish studies that pertain to a broad range of subject matter, including compound design and optimization, biological evaluation, drug delivery, imaging agents, and pharmacology of both small and large bioactive molecules. Specific areas include but are not limited to:
Identification, synthesis, and optimization of lead biologically active molecules and drugs (small molecules and biologics)
Biological characterization of new molecular entities in the context of drug discovery
Computational, cheminformatics, and structural studies for the identification or SAR analysis of bioactive molecules, ligands and their targets, etc.
Novel and improved methodologies, including radiation biochemistry, with broad application to medicinal chemistry
Discovery technologies for biologically active molecules from both synthetic and natural (plant and other) sources
Pharmacokinetic/pharmacodynamic studies that address mechanisms underlying drug disposition and response
Pharmacogenetic and pharmacogenomic studies used to enhance drug design and the translation of medicinal chemistry into the clinic
Mechanistic drug metabolism and regulation of metabolic enzyme gene expression
Chemistry patents relevant to the medicinal chemistry field.